MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 168 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2020. The put-call ratio across all filers is 1.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $206,000 | -5.9% | 23,232 | +3.6% | 0.00% | – |
| Q4 2019 | $219,000 | +11.7% | 22,427 | +8.4% | 0.00% | – |
| Q3 2019 | $196,000 | -26.0% | 20,697 | -7.1% | 0.00% | – |
| Q2 2019 | $265,000 | -57.4% | 22,281 | -36.9% | 0.00% | -100.0% |
| Q1 2019 | $622,000 | +11.5% | 35,304 | +9.8% | 0.00% | 0.0% |
| Q4 2018 | $558,000 | +4.5% | 32,143 | -10.3% | 0.00% | 0.0% |
| Q3 2018 | $534,000 | -27.0% | 35,836 | -21.9% | 0.00% | 0.0% |
| Q2 2018 | $732,000 | -3.0% | 45,899 | -13.7% | 0.00% | 0.0% |
| Q1 2018 | $755,000 | +10.2% | 53,176 | +8.6% | 0.00% | 0.0% |
| Q4 2017 | $685,000 | +26.6% | 48,947 | +28.4% | 0.00% | 0.0% |
| Q3 2017 | $541,000 | -92.3% | 38,109 | -91.4% | 0.00% | -92.3% |
| Q2 2017 | $7,050,000 | -47.7% | 443,346 | -55.1% | 0.01% | +8.3% |
| Q1 2017 | $13,474,000 | +60.4% | 987,038 | +108.0% | 0.01% | -25.0% |
| Q4 2016 | $8,398,000 | -35.8% | 474,474 | -30.1% | 0.02% | -33.3% |
| Q3 2016 | $13,090,000 | -43.9% | 678,608 | -43.3% | 0.02% | -48.9% |
| Q2 2016 | $23,320,000 | -49.3% | 1,195,886 | -45.2% | 0.05% | -50.5% |
| Q1 2016 | $45,958,000 | -5.7% | 2,182,220 | -8.1% | 0.10% | -5.9% |
| Q4 2015 | $48,730,000 | +66.0% | 2,374,758 | +38.3% | 0.10% | +62.9% |
| Q3 2015 | $29,362,000 | -1.7% | 1,717,080 | +5.8% | 0.06% | +5.1% |
| Q2 2015 | $29,881,000 | -4.5% | 1,623,080 | -0.8% | 0.06% | -3.3% |
| Q1 2015 | $31,274,000 | +169.5% | 1,635,680 | +132.0% | 0.06% | +165.2% |
| Q4 2014 | $11,605,000 | -99.9% | 705,046 | -0.4% | 0.02% | +35.3% |
| Q3 2014 | $12,518,258,000 | -20.8% | 707,646 | -7.6% | 0.02% | -15.0% |
| Q2 2014 | $15,801,035,000 | +37.0% | 765,554 | +44.7% | 0.02% | +53.8% |
| Q1 2014 | $11,530,266,000 | -14.2% | 529,154 | +4.5% | 0.01% | -23.5% |
| Q4 2013 | $13,437,445,000 | -18.1% | 506,500 | -27.1% | 0.02% | -57.5% |
| Q3 2013 | $16,416,456,000 | +259.0% | 694,700 | +226.6% | 0.04% | +233.3% |
| Q2 2013 | $4,573,050,000 | – | 212,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |